Institutional Ownership
Bridgebio Pharma Inc
CUSIP 10806XAD4NOTE 2.250% 2/0BBIOQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ssi Investment Management LLC | 6.08M | $6.80M |
| 2 | Bnp Paribas Asset Management Holding S.A. | 2.50M | $2.82M |
| 3 | Bank Of New York Mellon Corp | 1.00M | $1.13M |
| 4 | Sei Investments Co | 377.0K | $421.5K |
| 5 | Oppenheimer Asset Management Inc. | 105.0K | $117.4K |
| 6 | Stephens Inc /Ar/ | 33.0K | $36.9K |
| 7 | &Partners | 15.0K | $16.8K |